XML 75 R46.htm IDEA: XBRL DOCUMENT
v3.26.1

SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Earnings Per Share [Abstract] |
Schedule Of Preferred Stock | The table below presents preferred stock outstanding at SoCalGas:
PREFERRED STOCK OUTSTANDING
(Dollars in millions, except per share amounts)
| June 30, 2026 |  | December 31, 2025
$25 par value, authorized 1,000,000 shares: |  |  |
6% Series, 79,011 shares outstanding | $ | 3 |  |  | $ | 3 |
6% Series A, 783,032 shares outstanding | 19 |  |  | 19 |
SoCalGas - Total preferred stock | $ | 22 |  |  | $ | 22 |
Less: 50,970 shares of the 6% Series outstanding owned by Pacific Enterprises | (2) |  |  | (2) |
Sempra - Total preferred stock of subsidiary | $ | 20 |  |  | $ | 20 |
Schedule Of Sale Of Stock | The principal terms of these forward sale agreements at June 30, 2026 are as follows:
FORWARD SALE AGREEMENTS UNDER THE ATM PROGRAM THAT REMAIN SUBJECT TO FUTURE SETTLEMENT
(Dollars in millions, except per share amounts)
Date of agreement | Number of shares subject to agreement | Number of shares that remain to be settled | Initial forward price per share | Expected net proceeds(1) | Forward purchaser | Sales commissions | Final settlement date
November 18, 2024 | 2,909,274 | 2,909,274 | $92.1546 | $268 | Bank of America, N.A. | $2.4 | December 31, 2027
February 26, 2025 | 2,087,317 | 2,087,317 | $70.6593 | $147 | Wells Fargo Bank, N.A. | $1.3 | March 31, 2027
(1) Expected net proceeds assumes full physical settlement, is net of sales commission but does not deduct other equity issuance costs, and is subject to certain adjustments pursuant to the applicable forward sale agreement.
Schedule Of Transfers (To) From Noncontrolling Interest | The following table summarizes net income attributable to Sempra and transfers (to) from CRNCI and NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity.
NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM CRNCI AND NCI
(Dollars in millions)
| Three months ended |  | Six months ended
| June 30, 2026
Sempra: |  |  |
Net income attributable to Sempra | $ | 797 |  |  | $ | 1,834 |
Transfers (to) from CRNCI and NCI: |  |  |
Decrease in shareholders’ equity from allocation of interests(1) | (20) |  |  | (14) |
Net transfers (to) from CRNCI and NCI | (20) |  |  | (14) |
Change from net income attributable to Sempra and transfers (to) from CRNCI and NCI | $ | 777 |  |  | $ | 1,820 |
(1) We describe the allocation of interests in Note 10.
Schedule of Earnings Per Share, Basic and Diluted |
EARNINGS PER COMMON SHARE COMPUTATIONS
(Dollars in millions, except per share amounts; shares in thousands) |  |  |  |  |  |  |
| Three months ended June 30, |  | Six months ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Sempra: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Earnings attributable to common shares | $ | 796 |  |  | $ | 461 |  |  | $ | 1,833 |  |  | $ | 1,367 |
Denominator: |  |  |  |  |  |  |
Weighted-average common shares outstanding for basic EPS(1) | 654,038 |  |  | 652,664 |  |  | 653,815 |  |  | 652,330 |
Dilutive effect of common shares sold forward | 518 |  |  | 101 |  |  | 500 |  |  | 51 |
Dilutive effect of stock options and RSUs(2) | 1,389 |  |  | 459 |  |  | 1,403 |  |  | 742 |
Weighted-average common shares outstanding for diluted EPS | 655,945 |  |  | 653,224 |  |  | 655,718 |  |  | 653,123 |
EPS: |  |  |  |  |  |  |
Basic | $ | 1.22 |  |  | $ | 0.71 |  |  | $ | 2.80 |  |  | $ | 2.10 |
Diluted | $ | 1.21 |  |  | $ | 0.71 |  |  | $ | 2.80 |  |  | $ | 2.09 |
(1) Includes 365 and 499 fully vested RSUs held in our deferred compensation plan in the three months ended June 30, 2026 and 2025, respectively, and 375 and 507 of such RSUs in the six months ended June 30, 2026 and 2025, respectively. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued. (2) Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 14 of the Notes to Consolidated Financial Statements in the Annual Report, dilutive RSUs may vary widely from period-to-period.

X
- Definition Schedule Of Preferred Stock + References No definition available. + Details
Name: | sre_ScheduleOfPreferredStockTableTextBlock
Namespace Prefix: | sre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Sale Of Stock + References No definition available. + Details
Name: | sre_ScheduleOfSaleOfStockTableTextBlock
Namespace Prefix: | sre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Transfers (To) From Noncontrolling Interest + References No definition available. + Details
Name: | sre_ScheduleOfTransfersToFromNoncontrollingInterestTableTextBlock
Namespace Prefix: | sre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration